How to calculate ‘negative’ profits
QBTS stock isn't the dip-buying opportunity you think it is
The nomination of FDA critic RFK Jr. has cast a cloud over the biotech sector
PLTR stock is pricey but still deserves careful consideration
Bet on kinesis (or lack thereof) with the iron condor on RIOT stock
There’s still a potential SAVA stock play despite the heavy skepticism
With a likely push to make oil great again, XOM stock should benefit handsomely
A short iron condor beckons the extreme speculator
Smart players know to always take what the market gives you
